← FDA DRUG APPROVALS

FDA ANDA · ANDA085532

HYDRALAZINE HYDROCHLORIDE

Sponsor: WATSON LABS

APPLICATION
ANDA085532
TYPE
ANDA
ORIGINAL APPROVAL
1977-04-14
LATEST ACTION
1988-12-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HYDRALAZINE HYDROCHLORIDEDiscontinued
HYDRALAZINE HYDROCHLORIDE 25MG · TABLET · ORAL

Approval history

1988-12-23Labeling · Supplement 29AP
1977-04-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →